(2011) Current, new and future treatments of osteoporosis. Rheumatology International 31 , 289-300 /Salari Sharif P, Abdollahi M, Larijani B: Current, new and future treatments of osteoporosis. Rheumat Int 2011, 31 (3) : 289–300.
Osteoporosis is a multifactorial skeletal disorder characterized by decreased bone mass and deteriorated microarchitecture that lead to increased risk of fracture. The disuse osteoporosis refers to bone mass decrements under conditions of decreased mecha
Based on the evidence in the current medical literature, medications for used for the treatment of osteoporosis can also be effective for the treatment of OA. Of current medications, estrogen, SERMs, and bisphosphonates are the most studied and have the most promise as effective treatments for OA...
Current and future treatments of secondary osteoporosis Osteoporosis is commonly associated with menopause and ageing. It can, however, also be caused by diseases, lifestyle, genetic diseases, drug therapies and... R Soriano,S Herrera,X Nogués,... - 《Best Practice & Research Clinical Endocrinol...
Osteoporosis is a bone pathology leading to increase fractures risk and challenging quality of life. Since current treatments could exhibit deleterious sid... L Laurent,W Fabien,G Jér?Me,... - 《Plos One》 被引量: 49发表: 2013年 ACO Algorithm for MKP Using Various Heuristic Information Fid...
期刊名称:《Current Therapeutic Research, Clinical and Experimental》 | 2003年第5期 关键词: beta-cyclodextrin nimesulide dental pain; 43.Efficacy and Tolerability of Delapril Plus Indapamide Versus Lisinopril Plus Hydrochlorothiazide Combination Treatments in Mild to Moderate Hypertension: A Multicenter Ra...
In the present research, to provide ‘p’ and to overcome ‘P’ deficiency an attempt was made by inoculating AM fungi and phosphobacteria and interestingly all the treatments received either single inoculation or combined inoculation of AM fungi and phosphobacteira significantly improved yield of ...
Patient adherence to osteoporosis treatments is poor. In prospective studies, patients who underwent DXA subsequently had better adherence to their treatment regimen [23]. Several studies suggest that repeatedly performing DXA during osteoporosis therapy may be unnecessary. The results may fail to influenc...
Osteosarcopenia is a geriatric syndrome associated with disability and mortality. This review summarizes the key microRNAs that regulate the hallmarks of sarcopenia and osteoporosis. Our objective was to identify components similarly regulated in the pathology and have therapeutic potential by influencing cru...
Kimmel DB (2002) Animal models in osteoporosis research. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of bone biology, 2nd edn. Academic, San Diego, pp 1635–1655 Chapter Google Scholar Kimmel DB, Bozzato RP, Kronis KA et al (1993) The effect of recombinant human (1–84...